151 main st LLC

80 state st.
albany, new york 12207

NYS Entity Status
ACTIVE

NYS Filing Date
JANUARY 06, 2014

NYS DOS ID#
4508542

County
PUTNAM

Jurisdiction
NEW YORK

Registered Agent
CORPORATION SERVICE COMPANY
80 STATE ST.
ALBANY, NEW YORK, 12207

NYS Entity Type
DOMESTIC LIMITED LIABILITY COMPANY

Name History
2014 - 151 MAIN ST LLC









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • AROUND THE WEB

  • AquaBounty Lines Up First U.S. Fish Farm With Deal for Indiana Site
    By Frank Vinluan - Tuesday Jun 13, 2017

    When salmon from AquaBounty Technologies reach grocery stores and restaurants, some of them will come from America’s heartland. AquaBounty (NASDAQ: AQB) has agreed to pay $14 million in cash to acquire some of the assets of Bell Fish Company, including that company’s fish farm in Albany, IN. The deal will give Maynard, MA-based AquaBounty its […]

    Source: Xconomy VC, Deals, & Startups Feed
  • Greg David on NY: Why developing in Midtown remains a Herculean task
    Monday Jun 19, 2017



    To view the full story, click the title link.

    Source: Crain&apso;s New York Business
  • Pulse@MassChallenge Spurs Deals in Digital Health Lab’s 1st Session
    By Jeff Engel - Wednesday Jun 14, 2017

    The refrain among digital health startups is it can be difficult and time-consuming to convince hospitals and other healthcare organizations to try out their products, let alone buy them. Pulse@MassChallenge, a new Boston “lab” dedicated to supporting digital health ventures, matches startups with partner organizations—think hospitals, insurers, larger tech companies, nonprofits, and government entities—to collaborate […]

    Source: Xconomy VC, Deals, & Startups Feed
  • “It’s Shame On Us If We Blow It”: Highlights From NY Seizes the Momentum
    By Ben Fidler - Wednesday Jun 7, 2017

    Mike Foley, a drug industry veteran and director of the Tri-Institutional Therapeutics Discovery Institute, has a pointed message for the New York life sciences industry: Don’t waste the moment. Changing the course of New York biotech has been a saga that dates back to the 1990s, and as Xconomy has detailed, progress has been made […]

    Source: Xconomy New York
  • New Approvals Show FDA Is Adapting to Precision Medicine
    By Frank Vinluan - Tuesday May 30, 2017

    The randomized controlled trial has long been held up as the gold standard for testing new drugs. But the nation’s top drug evaluator, Janet Woodcock, believes they aren’t necessary for all new experimental treatments. Randomized trials are long, expensive to run, and ultimately produce limited answers, she said at a medical conference last week. The […]

    Source: Xconomy New York
  • “It’s Shame On Us If We Blow It”: Highlights From NY Seizes the Momentum
    By Ben Fidler - Wednesday Jun 7, 2017

    Mike Foley, a drug industry veteran and director of the Tri-Institutional Therapeutics Discovery Institute, has a pointed message for the New York life sciences industry: Don’t waste the moment. Changing the course of New York biotech has been a saga that dates back to the 1990s, and as Xconomy has detailed, progress has been made […]

    Source: Xconomy VC, Deals, & Startups Feed
  • Fit City: Taking Night-Life Cue, Gyms Lower the Lights
    By TATIANA BONCOMPAGNI - Tuesday Jun 13, 2017

    Cycling, boxing and running studios, as well as some full-service gyms, are using sophisticated lighting systems to heighten the exercise experience.

    Source: NYT > Home Page
  • Alexandria Debuts NY’s Latest Bio Incubator With 13 Startups in Tow
    By Ben Fidler - Tuesday Jun 13, 2017

    A new startup incubator has just opened in Manhattan this morning, adding to a growing list of facilities meant to help support seedling New York City biotechs. LaunchLabs, first announced by Alexandria Real Estate Equities a year ago, officially opened its doors and revealed the 13 startups that will grow there. LaunchLabs is a 15,000-square-foot […]

    Source: Xconomy New York